tinidazole has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tinidazole was indicated, 2 g/day for 5 days in the first week of CT started." | 1.51 | Tinidazole efficacy for amebic colitis therapeutic prophylaxis in patients with de novo acute leukemia receiving intensive chemotherapy. ( Alvarado-Ibarra, M; Álvarez-Vera, JL; Arana-Luna, LL; Espitia-Ríos, ME; Mena-Zepeda, V; Ortiz-Zepeda, M; Peña-Celaya, JA; Zúñiga, JMP, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arana-Luna, LL | 1 |
| Álvarez-Vera, JL | 1 |
| Peña-Celaya, JA | 1 |
| Mena-Zepeda, V | 1 |
| Ortiz-Zepeda, M | 1 |
| Espitia-Ríos, ME | 1 |
| Zúñiga, JMP | 1 |
| Alvarado-Ibarra, M | 1 |
1 other study available for tinidazole and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Tinidazole efficacy for amebic colitis therapeutic prophylaxis in patients with de novo acute leukemia receiving intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Amebicides; Antineoplastic Combined Chemotherapy Protocols; Dysentery, Ameb | 2019 |